scout
|Videos|June 19, 2017

Activity of Dabrafenib/Trametinib Combo in Patients With Melanoma Brain Metastases

Georgina V. Long, BSc, PhD, MBBS, professor of medical melanoma oncology, Melanoma Institute Australia, discusses the activity seen with the combination of dabrafenib and trametinib for the treatment of patients with melanoma brain metastases.

Newsletter

Stay up to date on practice-changing data in community practice.


Latest CME